Cephalon News

Teva Pharmaceutical Industries Ltd.'s Treanda worked better than a standard therapy and with fewer side effects to slow the growth of immune system tumors, a finding that could push more doctors to prescribe the drug as an initial treatment.

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics - strong fundamentals and a valuation that looks inexpensive.

SALT LAKE CITY &#8212 The U.S. Food and Drug Administration warned this week of fake versions of the ADHD medication Adderall that are being distributed online.

The U.S. Food and Drug Administration is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet.

Teva Pharmaceutical Industries began trading on the New York Stock Exchange Wednesday under the ticker symbol "TEVA," after the transfer of its stock listing from NASDAQ.

Warning: If you order Adderall over the Internet you might end up getting a counterfeit drug.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor.

Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 JERUSALEM -- -- On its conference call today, Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries cut its revenue and profit projections for 2012, blaming the drop on the sluggish economy worldwide and health-care reform measures taking place in Europe.

Investors may be a bit weary of jumping into PROLOR Biotech after the company announced the closing an underwritten public offering, but that hasn't kept billionaire Phil Frost, chairman of generic drugmaker Teva Pharmaceutical Industries from buying another big chunk of the company.

Gamida Cell has closed an internal E financing round of $10 million. All major shareholders participated, the company said.

Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant is seen December 21, 2011.